Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Journal of Neural Engineering
|
May 28, 2015
Implications of chronic daily anti-oxidant administration on the inflammatory response to intracortical microelectrodes
Kelsey A Potter-Baker, Wade G Stewart, William H Tomaszewski, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
ERβ limits T cell-mediated inflammation to maintain immune homeostasis
Sarah K McNeer, Alyssia V Broncano, Sarah M Stark, et al.
Gastro Hep Advances
|
April 29, 2025
Sex Differences in Colonic Inflammation are Driven by Epithelial-Specific Expression of Estrogen Receptor Alpha
Guillermo A Pereda, Adrian D Kocinski, Alyssia V Broncano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2005
Novel Phase I dose de-escalation design trial to determine the biological modulatory dose of the antiangiogenic agent SU5416
Afshin Dowlati, Kelly Robertson, Tomas Radivoyevitch, et al.
Journal of Biomedical Materials Research. Part A
|
April 10, 2020
Myocardial injection of a thermoresponsive hydrogel with reactive oxygen species scavenger properties improves border zone contractility
Kimberly A Spaulding, Yang Zhu, Kiyoaki Takaba, et al.
Plos One
|
September 26, 2009
Cell cycle re-entry and mitochondrial defects in myc-mediated hypertrophic cardiomyopathy and heart failure
Hyoung-gon Lee, Qun Chen, Julie A Wolfram, et al.
Journal of Neural Engineering
|
December 9, 2017
Inhibition of the cluster of differentiation 14 innate immunity pathway with IAXO-101 improves chronic microelectrode performance
John K Hermann, Madhumitha Ravikumar, Andrew J Shoffstall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2007
Inflammatory breast cancer as a model disease to study tumor angiogenesis: results of a phase IB trial of combination SU5416 and doxorubicin
Beth Overmoyer, Pingfu Fu, Charles Hoppel, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Journal of Neural Engineering
|
May 28, 2015
Implications of chronic daily anti-oxidant administration on the inflammatory response to intracortical microelectrodes
Kelsey A Potter-Baker, Wade G Stewart, William H Tomaszewski, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
ERβ limits T cell-mediated inflammation to maintain immune homeostasis
Sarah K McNeer, Alyssia V Broncano, Sarah M Stark, et al.
Gastro Hep Advances
|
April 29, 2025
Sex Differences in Colonic Inflammation are Driven by Epithelial-Specific Expression of Estrogen Receptor Alpha
Guillermo A Pereda, Adrian D Kocinski, Alyssia V Broncano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2005
Novel Phase I dose de-escalation design trial to determine the biological modulatory dose of the antiangiogenic agent SU5416
Afshin Dowlati, Kelly Robertson, Tomas Radivoyevitch, et al.
Journal of Biomedical Materials Research. Part A
|
April 10, 2020
Myocardial injection of a thermoresponsive hydrogel with reactive oxygen species scavenger properties improves border zone contractility
Kimberly A Spaulding, Yang Zhu, Kiyoaki Takaba, et al.
Plos One
|
September 26, 2009
Cell cycle re-entry and mitochondrial defects in myc-mediated hypertrophic cardiomyopathy and heart failure
Hyoung-gon Lee, Qun Chen, Julie A Wolfram, et al.
Journal of Neural Engineering
|
December 9, 2017
Inhibition of the cluster of differentiation 14 innate immunity pathway with IAXO-101 improves chronic microelectrode performance
John K Hermann, Madhumitha Ravikumar, Andrew J Shoffstall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2007
Inflammatory breast cancer as a model disease to study tumor angiogenesis: results of a phase IB trial of combination SU5416 and doxorubicin
Beth Overmoyer, Pingfu Fu, Charles Hoppel, et al.
Page
of 2